---
title: "SYMBIOSIS PHARMACEUTICAL SERVICES LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/0ea92f33-17cf-4d2d-b5ee-3682c396c1a8
json: https://whiteintel.dev/api/public/dossier/0ea92f33-17cf-4d2d-b5ee-3682c396c1a8
identifier: gb-coh:SC373596
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SYMBIOSIS PHARMACEUTICAL SERVICES LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `gb-coh:SC373596`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/0ea92f33-17cf-4d2d-b5ee-3682c396c1a8  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/0ea92f33-17cf-4d2d-b5ee-3682c396c1a8  

## Ownership & control

### Owners / controllers

- **SCOTTISH ENTERPRISE GLASGOW** (beneficial owner) — 37.5% — https://whiteintel.dev/entity/622b2d29-a57b-5f2c-b87d-d5fe4b4455b1
- **SYMBIOSIS HOLDINGS (SCOTLAND) LTD** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/78d9fe68-69f4-5013-b7ee-2c1a5d01dfd7

### UBO chain (walk to the ultimate owner)

A **5-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `SC373596`
- **Status:** active
- **Type:** ltd
- **Incorporated:** 2010-02-24
- **Registered office:** Unit 10 Scion House, Stirling University Innovation Park, Stirling, FK9 4NF
- **SIC:** 21100

### Officers

- MACKAY, Colin Smith — director · British · appointed 2010-03-16
- MERTEN, Gerry — director · British · appointed 2016-02-19
- REEKIE, Robert Morris, Dr — director · British · appointed 2015-01-15
- ANDERSON, Joanne — director · British · appointed 2017-05-24 · resigned 2019-01-25
- BAL, Sukhpal Singh — director · British · appointed 2011-07-22 · resigned 2020-11-20
- BATH, David Simon — director · British · appointed 2011-03-04 · resigned 2012-02-23
- LONG, Kenneth Burnie — director · British · appointed 2010-02-24 · resigned 2010-03-16
- MARRIAGE, Howard John, Dr — director · British · appointed 2011-03-17 · resigned 2016-01-13
- MCCORMICK, John James — director · Scottish · appointed 2020-03-25 · resigned 2026-02-23
- MCKAY, Murray David — director · British · appointed 2011-03-04 · resigned 2016-09-02
- PETTIE, Bruce Douglas — director · British · appointed 2011-03-17 · resigned 2013-09-21
- PORTER, John Francis, Dr — director · British · appointed 2011-03-04 · resigned 2013-05-22
- WESTON, Fintan Alexander — director · British · appointed 2012-04-16 · resigned 2016-11-18

### Beneficial owners (Persons with Significant Control)

- [Symbiosis Holdings (Scotland) Ltd](https://whiteintel.dev/entity/78d9fe68-69f4-5013-b7ee-2c1a5d01dfd7) — 75–100% shares · corporate PSC · Scotland — since 2020-10-02
- [Scottish Enterprise](https://whiteintel.dev/entity/622b2d29-a57b-5f2c-b87d-d5fe4b4455b1) — 25–50% shares · corporate PSC · Scotland — ceased 2020-10-02

## Provenance

- companies_house_bulk — https://find-and-update.company-information.service.gov.uk/company/SC373596

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **SYMBIOSIS PHARMACEUTICAL SERVICES LIMITED** — https://whiteintel.dev/entity/0ea92f33-17cf-4d2d-b5ee-3682c396c1a8 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SYMBIOSIS PHARMACEUTICAL SERVICES LIMITED**. Human view: https://whiteintel.dev/entity/0ea92f33-17cf-4d2d-b5ee-3682c396c1a8 · Structured JSON: https://whiteintel.dev/api/public/dossier/0ea92f33-17cf-4d2d-b5ee-3682c396c1a8._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._